The crucial role of N6-methyladenosine modification in acute kidney injury: mechanisms and therapeutic potential - Takeaways - MDSpire

The crucial role of N6-methyladenosine modification in acute kidney injury: mechanisms and therapeutic potential

  • By

  • Xuechao Zhang

  • Xiaoshan Chen

  • Lizhu Yang

  • Yanan Jin

  • Weiran Zhang

  • Jinge Zhang

  • Jiaguo Huang

  • July 13, 2026

Share

  • 1

    Acute kidney injury (AKI) is a critical condition with high mortality, characterized by a rapid decline in renal function.

  • 2

    N6-methyladenosine (m6A) is a significant post-transcriptional modification that regulates various RNA processes.

  • 3

    m6A modification influences renal tubular epithelial cell fate by regulating inflammatory responses and programmed cell death.

  • 4

    Dysregulation of m6A modification is implicated in the pathogenesis of AKI and may affect renal repair processes.

  • 5

    Targeting m6A regulatory elements presents potential for novel diagnostic biomarkers and therapeutic strategies for AKI.

Original Source(s)

The crucial role of N6-methyladenosine modification in acute kidney injury: mechanisms and therapeutic potential

  • by Xuechao Zhang, Xiaoshan Chen, Lizhu Yang, Yanan Jin, Weiran Zhang, Jinge Zhang, Jiaguo Huang

  • July 13, 2026

Related Content

Can GDMT Be Safely Stopped After AF Ablation?

Three of 23 patients experienced heart failure deterioration following medication withdrawal, while adverse drug events occurred only among patients who continued therapy.

Effects of statins on functional capacity and cardiac remodeling in patients with heart failure and preserved ejection fraction: a randomized open-label pilot trial

Association between clinical characteristics within 6 h of ICU admission and 30-day mortality risk in immunocompromised sepsis patients: development and validation of a machine learning model based on the MIMIC-IV database